Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Share-based Compensation (2015 - 2026)

Sol-Gel Technologies (SLGL) posted quarterly Share-based Compensation of $100000.0 for Q2 2025, down 63.64% year-over-year from $275000.0 in Q2 2024, and down 63.64% quarter-over-quarter from $275000.0 in Q2 2024.

Analysis

Sol-Gel Technologies (SLGL) Share-based Compensation (2015 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Share-based Compensation for 8 consecutive years, with $100000.0 the latest figure, recorded in Q2 2025.

  • In Q2 2025, Share-based Compensation fell 63.64% year-over-year to $100000.0; the TTM figure through Jun 2025 stood at $1.2 million (down 8.45% YoY), while the FY2025 annual figure was $82000.0, down 89.57% from the prior year.
  • Share-based Compensation slipped to $100000.0 in Q2 2025 per SLGL's latest filing, from $275000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $498000.0 in Q2 2023 and bottomed at $100000.0 in Q2 2025.
  • Historically, Share-based Compensation has averaged $287600.0 across 5 years, with a median of $275000.0 in 2024.
  • Annual changes were most pronounced in 2022 — Share-based Compensation surged 65.26% — and 2025, when it slumped 63.64%.
  • Sol-Gel Technologies' Share-based Compensation stood at $213000.0 in 2021, then surged by 65.26% to $352000.0 in 2022, then surged by 41.48% to $498000.0 in 2023, then slumped by 44.78% to $275000.0 in 2024, then plunged by 63.64% to $100000.0 in 2025.
  • Business Quant data shows SLGL's Share-based Compensation at $100000.0 in Q2 2025, $275000.0 in Q2 2024, and $498000.0 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn - 154,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 154,000.00
Jun 30, 2025 100,000.00
Jun 30, 2024 275,000.00
Jun 30, 2023 498,000.00
Jun 30, 2022 352,000.00
Jun 30, 2021 213,000.00
Jun 30, 2020 315,000.00
Dec 31, 2018 2.93 Mn
Dec 31, 2017 849,780.00
Dec 31, 2016 402,955.00
Dec 31, 2015 312,194.00